• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

9.810 -0.990 (-9.17%)
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 275,441
Open 10.56
Bid (Size) 9.810 (500)
Ask (Size) 10.00 (300)
Prev. Close 10.80
Today's Range 9.720 - 10.79
52wk Range 4.510 - 69.00
Shares Outstanding 13,012,866
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are moving on Thursday? ↗
October 15, 2026
Via Chartmill
Top movers in Tuesday's pre-market session ↗
July 14, 2026
Via Chartmill

Performance

52-Week Range 85.8% below 52-week high
9.810
4.5152W Low 69.0052W High
1 Week 13.2% below 1-week high
8.831W Low 11.301W High

Regencell Bioscience Holdings Limited - Ordinary Shares (RGC) traded between $4.51 and $69.00 over the past 52 weeks and last traded at $9.81, 85.8% below its 52-week high. Over the past week it ranged between $8.83 and $11.30.

Past 12 Months
+2.3%
+57.5%
+74.6%
-65.3%
-52.2%
-37.7%
1W +$0.22
1M +$3.58
3M +$4.19
6M -$18.50
YTD -$10.73
1Y -$5.94

RGC was -37.7% over the past year, -65.3% over six months, -52.2% year to date, +2.3% in the last week.

12 Months vs Market
RGC
-37.7%
DIA
+13.3%
SPY
+14.4%
QQQ
+16.3%
IWM
+13.7%

Over the past 12 months RGC returned -37.7% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 1.15× 3-mo avg
Today 275,441 3-mo avg 238.6K
1W
487.5K
1M
341.3K
3M
238.6K
6M
256.4K
YTD
297.7K
1Y
281.2K

RGC most recently traded 275,441 shares against a 3-month average daily volume of 238.6K.

More News

Read More
Unusual volume stocks are being observed in Monday's session. ↗
July 06, 2026
Via Chartmill
Which stocks are moving on Wednesday? ↗
July 01, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
July 01, 2026
Via Benzinga
Keep an eye on the top gainers and losers in Wednesday's session. ↗
July 01, 2026
Via Chartmill
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
June 23, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
June 23, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
June 23, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
REGENCELL DEADLINE JUNE 23rd: Bragar Eagel & Squire, P.C. Urgently Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
June 22, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
June 22, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
June 20, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
REGENCELL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
June 18, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
REGENCELL DEADLINE TUESDAY JUNE 23rd: Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
June 17, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
June 16, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
June 13, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
June 12, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
REGENCELL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100Kto Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
June 12, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
June 09, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
REGENCELL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
June 09, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
June 04, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
June 02, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
June 02, 2026
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm Before June 23rd
May 29, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
May 26, 2026
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Regencell Bioscience Holdings Limited - Ordinary Shares publicly traded?
Yes, Regencell Bioscience Holdings Limited - Ordinary Shares is publicly traded.
What exchange does Regencell Bioscience Holdings Limited - Ordinary Shares trade on?
Regencell Bioscience Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares?
The ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares is RGC on the Nasdaq Stock Market
What is the current price of Regencell Bioscience Holdings Limited - Ordinary Shares?
The current price of Regencell Bioscience Holdings Limited - Ordinary Shares is 9.810
When was Regencell Bioscience Holdings Limited - Ordinary Shares last traded?
The last trade of Regencell Bioscience Holdings Limited - Ordinary Shares was at 10/22/26 04:00 PM ET
What is the market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares?
The market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares is 127.66M
How many shares of Regencell Bioscience Holdings Limited - Ordinary Shares are outstanding?
Regencell Bioscience Holdings Limited - Ordinary Shares has 128M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap